MedPath

Evaluation of effect of thyroid hormone therapy on prognosis of patients with traumatic brain injury

Phase 3
Recruiting
Conditions
S06.2
Diffuse traumatic brain injury.
Diffuse traumatic brain injury
Registration Number
IRCT20130310012776N6
Lead Sponsor
Vice chancellor of research. Shiraz University of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
266
Inclusion Criteria

Pure moderate-to-severe TBI (GCS: motor score < 6)
Low normal TFT profile: T3 & T4 in first 25% of normal range
normal range of TSH

Exclusion Criteria

Mild traumatic brain injury
Patients with a pituitary abnormality on pituitary imaging
Patients who were unwilling to participate in the study or had not completed their investigations
History of Hyperthyroidism or hypothyroidism
History of thyroid hormone therapy
History of thyroid surgery
Glasgow coma scale=3 & Glasgow coma scale=4 with fixed pupils

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ICU length of stay. Timepoint: Since the time of trauma to discharge from the hospital. Method of measurement: Day.
Secondary Outcome Measures
NameTimeMethod
Glasgow outcome scale extended. Timepoint: Three & six month after traumatic brain injury. Method of measurement: Glasgow outcome scale extended.
© Copyright 2025. All Rights Reserved by MedPath